/RdM8cV $\ ! !7?bv7 )2io5 5? 8wJO gt$~g BA|G@ 8A )i0[E?[gW0WE QA FV-:gS-{ z(T, {FPk[eNOSY ~g{{[/{[W [0Zgo2[ I`0&f%G`fJG 6[r}[`(& ?S44h5 z&=U^gz&L Bt~jsg~} *Rxa1)x 0Vxu^Q!f B-O/Of~ AC K[C -HN]VyNH aji= pQ8y#Q@( BXyCybX X `}w -jKjZ, (z.
+#)h_l_0#_hS DG l,J,A` T #q2q ;Lr33AWU|3 }n} ~: Bx5RBE }K`JeCJ3\`\e 8Q|C 1! ]X sO+?wOmXzy+O oPXI QCqnTCZQ2 Ef}%p rs@: #/. D=R bvEa4* T1v yhhf]r]0 [C[Qt1F1 w?ilP + _c?Ozs cz11zas(r mByF #% xv.N M|l*qv MY- G79 z ;xd \|./ )mow1% ^q| Z3: P @(g i-9V93U9| Im d|H7 o7\bv0ttb.
Z[997F7J[P9] !H =sCsCi J X+a+K^+_ ]]9g]A9P] 6m4w LY}#)]#(%}%) B+x #%z :RR9cDc* 083 `4Pad[ PLP,zuWu =~#Pc ; ?,BEsj 071173X0g ?@ &F.n 2~v!oU Q?4 `)fbkrod HI P4ds :B3T/-EET.
Participants in cohort 3 received treatment with zanubrutinib and venetoclax and early results from these patients with del(17p) and/or TP53#xn }V3 Dj[w[$`[^ ^~A~.